Bajaj Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on May 08, 2026, recommended Final Dividend of Rs. 1.50 per equity share.
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.1 pts less than Nifty Microcap 250 and 10.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bajaj Healthcare reported Total Income of Rs. 61,816.68 Lakhs for FY26, up 10% from Rs. 56,200.68 Lakhs in FY25. However, Profit After Tax from continuing operations dropped significantly to Rs. 2,131.04 Lakhs from Rs. 4,292.88 Lakhs (down ~50%) due to a Rs. 3,324.66 Lakh exceptional charge from reversing income recognition related to a Middle East customer deal disrupted by regional instability. The Board recommended a Final Dividend of Rs. 1.50 per equity share (30% of Rs. 5 face value) for FY26, subject to shareholder approval at the AGM. Discontinued operations (assets held for sale) reported a loss of Rs. 554.43 Lakhs. The auditors issued an unmodified opinion on the financial statements.
Despite lower profits, the dividend recommendation signals the Board remains committed to shareholder returns. The significant profit decline and exceptional charge may create short-term stock pressure, but the clean audit opinion and revenue growth provide some stability for investors.